Aragon Pharmaceuticals, Inc.;Sloan Kettering Institute For Cancer Research
发明人:
申请号:
EP19169275.5
公开号:
EP3533792A1
申请日:
2013.06.04
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
Described herein are amorphous and crystalline forms of the androgen receptor modulator 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide. Also described are pharmaceutical compositions suitable for administration to a mammal that include the androgen receptor modulator, and methods of using the androgen receptor modulator, alone and in combination with other compounds, for treating diseases or conditions that are associated with androgen receptor activity.